As of Oct 5, 2026 close
- Market cap
- $23.75B
- P/E (TTM)
- 30.13
- Forward P/E
- 37.36
- Dividend yield
- -
- 52-week range
- $23.62$40.17
- Volume (live)
- -
- Avg. volume (3M)
- 3.06M
Genmab A/S (GMAB) Stock Price & Financial Analysis
Genmab A/S Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $36.27 - $37.87 |
|---|---|
| 52-Week High | $40.17 |
| 52-Week Low | $23.62 |
| Open | $37.28 |
| Volume (last close) | 4.25M |
| Average Volume (3M) | 3.06M |
| Market Cap | 23.75B |
|---|---|
| Shares Outstanding | 617.11M |
| P/E Ratio (TTM) | 30.13 |
| Forward P/E | 37.36 |
| Price to Sales (P/S) | 5.74 |
| Price to Book (P/B) | 3.99 |
| EV/EBITDA | 22.65 |
| Revenue (TTM) | 4.13B |
|---|---|
| Net Income (TTM) | 788.20M |
| Free Cash Flow (TTM) | 867.99M |
| EPS (TTM) | $1.58 |
| Profit Margin | 19.06% |
| Operating Margin | 32.29% |
| Return on Equity (ROE) | 13.23% |
| Debt to Equity | 0.86 |
| 50-Day MA | $33.20 |
|---|---|
| 200-Day MA | $29.72 |
| 1-Year Change | +17.53% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Genmab A/S at a Glance
Genmab A/S (GMAB) has a market capitalization of $23.75B. The stock trades at 30.1× trailing earnings, 37.4× forward earnings and 5.7× sales. Over the trailing twelve months it earned $788.20M on revenue of $4.13B (a 19.1% profit margin) and generated $867.99M of free cash flow. Revenue fell 43.5% year over year.
It holds $1.50B in cash and securities against $5.13B of debt, a net debt position of $3.63B.
Genmab A/S does not currently pay a dividend.
The share price is up 17.5% over the past year. At $36.65 it sits within its 52-week range of $23.62 to $40.17, above its 200-day moving average of $29.72.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $491.85, 1242.0% above the latest close.
Frequently Asked Questions About Genmab A/S
What is the current stock price for GMAB?
As of the Oct 7, 2026 close, GMAB stock trades at $36.65. The 52-week range is $23.62–$40.17, with a day range of $36.27–$37.87.
What is the P/E ratio for GMAB?
Genmab A/S's trailing P/E ratio is 30.1, meaning investors pay $30.1 for every $1 of annual earnings. The forward P/E is 37.4, reflecting analyst expectations for future earnings. Genmab A/S operates in the Healthcare sector.
Does GMAB pay dividends?
Genmab A/S does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GMAB?
Based on 11 analysts, the consensus for GMAB is Buy.
What is the market cap of GMAB?
Genmab A/S's market capitalization is $22.62B, classifying it as a large-cap company. Genmab A/S operates in the Healthcare sector within the Biotechnology industry.